← Back to Bills
HR 5143118th CongressFailed / ExpiredHouse

Vaccine Access Improvement Act of 2023

Policy Area: Taxation
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 20, 2024
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Vaccine Access Improvement Act of 2023 is a bill introduced in the 118th Congress aimed at improving access to vaccines. The bill was referred to the Subcommittee on Health but did not advance further and is currently classified as failed or expired. The bill falls under the policy area of Taxation, though specific provisions and mechanisms are not provided in the available data. No official summary or full text is available, limiting detailed analysis of its content or intended measures.

Bottom Line

The Vaccine Access Improvement Act of 2023 sought to enhance vaccine access but did not progress beyond initial referral and is now expired, with limited publicly available details on its provisions.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
  • It is categorized under the policy area of Taxation, suggesting a possible fiscal or tax-related approach to vaccine access.
  • No official summary or full text is available, restricting detailed understanding of the bill's specific proposals or mechanisms.
Who Benefits?

['Potential beneficiaries could include individuals seeking improved vaccine access, healthcare providers, and public health agencies, although specific beneficiaries cannot be identified due to lack of detailed text.']

Potential Concerns

['Lack of available full text and official summary limits assessment of implementation challenges, cost implications, or oversight provisions.', "Uncertainty about the bill's specific taxation-related mechanisms or authorities.", 'Potential policy tradeoffs related to taxation and healthcare access cannot be evaluated without further details.']

Political Context

The bill was introduced in the House and referred to the Subcommittee on Health but did not advance further, resulting in its failed or expired status. The absence of detailed legislative progress or debate records limits insight into the broader political environment or support levels.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could have influenced tax policy related to healthcare or vaccine distribution, potentially affecting public health funding or incentives.', 'Improved vaccine access might have downstream effects on public health outcomes and healthcare system burdens, though specifics are unknown.']

GovScope Watchdog Notes

The absence of both full bill text and an official summary significantly limits transparency and public understanding of the Vaccine Access Improvement Act of 2023. This lack of information restricts oversight capabilities and informed analysis by stakeholders. Additionally, the bill's failure to progress beyond subcommittee referral suggests limited legislative momentum or support.

Passage Likelihood: LowConfidence: 40%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready